Philip Booth

Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial

Michael Mullen, Xu Yu Jin, Anne H. Child et al. · The Lancet · 2019 · 133 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Neonatal examination and screening trial (NEST): a randomised, controlled, switchback trial of alternative policies for low risk infants   Commentary: "Switchback" allocation---dangerous bends ahead!

Cathryn Glazener, Craig Ramsay, Marion Campbell et al. · BMJ · 1999 · 45 citations · Full text

Public Health, Child Health, Pediatrics +15

Family studies in chromosome 22q11 deletion: further demonstration of phenotypic heterogeneity

Duminda De Silva, P Duffty, Philip Booth et al. · Clinical Dysmorphology · 1995 · 29 citations

Medicine, Genetics, Pediatrics +16

Chromosome 22q11 microdeletion and congenital heart disease - a survey in a paediatric population

Dongeun Yong, Philip Booth, J. Baruni et al. · European Journal of Pediatrics · 1999 · 16 citations

Medicine, Genetics, Pediatrics +16